Vaxart, Inc. Variable Lease, Cost
Vaxart, Inc. (VXRT) reported Variable Lease, Cost of $222.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-06
- Vaxart, Inc. variable lease, cost for the quarter ending 2026-06-30 was $222.00K, a 48.73% decline year-over-year.
- Vaxart, Inc. variable lease, cost for the quarter ending 2026-03-31 was $365.00K, a 30.36% increase year-over-year.
- Vaxart, Inc. variable lease, cost for the quarter ending 2025-06-30 was $433.00K, a 13.65% increase year-over-year.
- Vaxart, Inc. variable lease, cost for the quarter ending 2025-03-31 was $280.00K, a 44.44% decline year-over-year.
- Vaxart, Inc. variable lease, cost for fiscal 2023 was $1.86M, a 42.07% increase from fiscal 2022.
- Vaxart, Inc. variable lease, cost for fiscal 2022 was $1.31M, a 6.41% increase from fiscal 2021.
- Vaxart, Inc. variable lease, cost for fiscal 2021 was $1.23M, a 367.05% increase from fiscal 2020.
- Vaxart, Inc. variable lease, cost for fiscal 2020 was $264.00K, a 62.96% increase from fiscal 2019.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $222.00K 10-Q · filed 2026-08-06 | $587.00K 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $365.00K S-1 · filed 2026-05-08 | |||
| 2025-12-31 | $1.43M S-1 · filed 2026-05-08 | |||
| 2025-06-30 | $433.00K 10-Q · filed 2026-08-06 | $713.00K 10-Q · filed 2026-08-06 | $1.21M derived: sum of 3 quarters · filed 2026-08-06 | $1.70M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $280.00K S-1 · filed 2026-05-08 | $775.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.27M derived: sum of 3 quarters · filed 2026-05-08 | $1.65M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $495.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | $991.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.37M derived: sum of 3 quarters · filed 2026-05-08 | $1.88M S-1 · filed 2026-05-08 |
| 2024-09-30 | $496.00K 10-Q · filed 2024-11-13 | $877.00K derived: sum of 2 quarters · filed 2024-11-13 | $1.38M 10-Q · filed 2024-11-13 | $1.84M derived: sum of 4 quarters · filed 2025-03-20 |
| 2024-06-30 | $381.00K 10-Q · filed 2024-08-08 | $885.00K 10-Q · filed 2024-08-08 | $1.35M derived: sum of 3 quarters · filed 2025-03-20 | $1.81M derived: sum of 4 quarters · filed 2025-03-20 |
| 2024-03-31 | $504.00K 10-Q · filed 2024-05-13 | $967.00K derived: sum of 2 quarters · filed 2025-03-20 | $1.43M derived: sum of 3 quarters · filed 2025-03-20 | $1.86M derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-12-31 | $463.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $922.00K derived: sum of 2 quarters · filed 2025-03-20 | $1.35M derived: sum of 3 quarters · filed 2025-03-20 | $1.86M 10-K · filed 2025-03-20 |
| 2023-09-30 | $459.00K 10-Q · filed 2024-11-13 | $890.00K derived: sum of 2 quarters · filed 2024-11-13 | $1.40M 10-Q · filed 2024-11-13 | $1.79M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $431.00K 10-Q · filed 2024-08-08 | $942.00K 10-Q · filed 2024-08-08 | $1.33M derived: sum of 3 quarters · filed 2024-08-08 | $1.73M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $511.00K 10-Q · filed 2024-05-13 | $897.00K derived: sum of 2 quarters · filed 2024-05-13 | $1.29M derived: sum of 3 quarters · filed 2024-05-13 | $1.56M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $386.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $783.00K derived: sum of 2 quarters · filed 2024-03-14 | $1.05M derived: sum of 3 quarters · filed 2024-03-14 | $1.31M 10-K · filed 2024-03-14 |
| 2022-09-30 | $397.00K 10-Q · filed 2023-11-02 | $661.00K derived: sum of 2 quarters · filed 2023-11-02 | $926.00K 10-Q · filed 2023-11-02 | $1.22M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $264.00K 10-Q · filed 2023-08-03 | $529.00K 10-Q · filed 2023-08-03 | $825.00K derived: sum of 3 quarters · filed 2023-08-03 | $1.14M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $265.00K 10-Q · filed 2023-05-04 | $561.00K derived: sum of 2 quarters · filed 2023-05-04 | $874.00K derived: sum of 3 quarters · filed 2023-05-04 | $1.21M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $296.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $609.00K derived: sum of 2 quarters · filed 2023-03-15 | $940.00K derived: sum of 3 quarters · filed 2023-03-15 | $1.23M 10-K · filed 2023-03-15 |
| 2021-09-30 | $313.00K 10-Q · filed 2022-11-09 | $644.00K derived: sum of 2 quarters · filed 2022-11-09 | $937.00K 10-Q · filed 2022-11-09 | $1.15M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $331.00K 10-Q · filed 2022-08-08 | $624.00K 10-Q · filed 2022-08-08 | $835.00K derived: sum of 3 quarters · filed 2022-08-08 | $864.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $293.00K 10-Q · filed 2022-05-09 | $504.00K derived: sum of 2 quarters · filed 2022-05-09 | $533.00K derived: sum of 3 quarters · filed 2022-05-09 | $546.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $211.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $240.00K derived: sum of 2 quarters · filed 2022-02-24 | $253.00K derived: sum of 3 quarters · filed 2022-02-24 | $264.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $29.00K 10-Q · filed 2021-11-04 | $42.00K derived: sum of 2 quarters · filed 2021-11-04 | $53.00K 10-Q · filed 2021-11-04 | $83.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $13.00K 10-Q · filed 2021-08-05 | $24.00K 10-Q · filed 2021-08-05 | $54.00K derived: sum of 3 quarters · filed 2022-02-24 | $98.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $11.00K 10-Q · filed 2021-05-06 | $41.00K derived: sum of 2 quarters · filed 2022-02-24 | $85.00K derived: sum of 3 quarters · filed 2022-02-24 | $125.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $74.00K derived: sum of 2 quarters · filed 2022-02-24 | $114.00K derived: sum of 3 quarters · filed 2022-02-24 | $162.00K 10-K · filed 2022-02-24 |
| 2019-09-30 | $44.00K 10-Q · filed 2020-11-12 | $84.00K derived: sum of 2 quarters · filed 2020-11-12 | $132.00K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $40.00K 10-Q · filed 2020-08-06 | $88.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $48.00K 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |